Skip Nav Destination
Issues
1 January 2010
-
Cover Image
Cover Image
Tumor microenvironment conditions, such as hypoxia, have emerged as important components contributing to dendritic cell dysfunction. However, little is known about the molecular mechanism(s) behind this dysfunction. Previous studies by Zhang and colleagues show that tumor-derived factors may upregulate SOCS3 expression. Interestingly, immunoprecipitation combined with MALDI-TOF/TOF-MS/MS and pull-down analysis reveals the interaction of SOCS3 with M2-PK, as examined by confocal fluorescence microscopy. Importantly, M2-PK activity can be downregulated by SOCS3. Since M2-PK plays a critical role in producing ATP through glycolysis, this may represent a novel mechanism for dendritic cell dysfunction in the tumor microenvironment. For details, see the article by Zhang and colleagues on page 89 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Editorial
Reviews
Meeting Reports
Systems Biologists Seek Fuller Integration of Systems Biology Approaches in New Cancer Research Programs
Olaf Wolkenhauer; Charles Auffray; Simone Baltrusch; Nils Blüthgen; Helen Byrne; Marta Cascante; Andrea Ciliberto; Trevor Dale; Dirk Drasdo; David Fell; James E. Ferrell, Jr.; Daniel Gallahan; Robert Gatenby; Ulrich Günther; Brian D. Harms; Hanspeter Herzel; Christian Junghanss; Manfred Kunz; Ingeborg van Leeuwen; Philippe Lenormand; Francis Levi; Michael Linnebacher; John Lowengrub; Philip K. Maini; Arif Malik; Katja Rateitschak; Owen Sansom; Reinhold Schäfer; Karsten Schürrle; Christine Sers; Santiago Schnell; Darryl Shibata; John Tyson; Julio Vera; Michael White; Boris Zhivotovsky; Robert Jaster
Priority Reports
Matrix Metalloproteinase-7 and Premalignant Host Responses in Helicobacter pylori–Infected Mice
Seth R. Ogden; Jennifer M. Noto; Shannon S. Allen; Dilan A. Patel; Judith Romero-Gallo; M. Kay Washington; Barbara Fingleton; Dawn A. Israel; Nuruddeen D. Lewis; Keith T. Wilson; Rupesh Chaturvedi; Zhiguo Zhao; Yu Shyr; Richard M. Peek, Jr.
Clinical Studies
Integrated Systems and Technologies
Microenvironment and Immunology
Molecular and Cellular Pathobiology
Prevention and Epidemiology
Therapeutics, Targets, and Chemical Biology
α2-Macroglobulin Inhibits the Malignant Properties of Astrocytoma Cells by Impeding β-Catenin Signaling
Inge Lindner; Nasr Y.A. Hemdan; Martin Buchold; Klaus Huse; Marina Bigl; Ilka Oerlecke; Albert Ricken; Frank Gaunitz; Ulrich Sack; Andreas Naumann; Margrit Hollborn; Dietmar Thal; Rolf Gebhardt; Gerd Birkenmeier
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
Christine M. Chresta; Barry R. Davies; Ian Hickson; Tom Harding; Sabina Cosulich; Susan E. Critchlow; John P. Vincent; Rebecca Ellston; Darren Jones; Patrizia Sini; Dominic James; Zoe Howard; Phillippa Dudley; Gareth Hughes; Lisa Smith; Sharon Maguire; Marc Hummersone; Karine Malagu; Keith Menear; Richard Jenkins; Matt Jacobsen; Graeme C.M. Smith; Sylvie Guichard; Martin Pass
Functional Genetic Polymorphisms in the Aromatase Gene CYP19 Vary the Response of Breast Cancer Patients to Neoadjuvant Therapy with Aromatase Inhibitors
Liewei Wang; Katarzyna A. Ellsworth; Irene Moon; Linda L. Pelleymounter; Bruce W. Eckloff; Yvette N. Martin; Brooke L. Fridley; Gregory D. Jenkins; Anthony Batzler; Vera J. Suman; Saranya Ravi; J. Michael Dixon; William R. Miller; Eric D. Wieben; Aman Buzdar; Richard M. Weinshilboum; James N. Ingle
Tumor and Stem Cell Biology
Receptor Channel TRPC6 Is a Key Mediator of Notch-Driven Glioblastoma Growth and Invasiveness
Srinivasulu Chigurupati; Rajarajeswari Venkataraman; Daniel Barrera; Anusha Naganathan; Meenu Madan; Leena Paul; Jogi V. Pattisapu; George A. Kyriazis; Kiminobu Sugaya; Sergey Bushnev; Justin D. Lathia; Jeremy N. Rich; Sic L. Chan
Obituary
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.